RocketAbs

Cut Weeks from Immunization Timelines with RocketAbs

Faster than competitors

Weeks saved compared to standard protocols

Less antigen than standard protocols

RocketAbs: a Protocol Built for Today’s Deadlines

In vivo humanization generates custom antibodies with minimal engineering while preserving natural in vivo selection. But standard immunization protocols are slow and require large amounts of antigen, even when supply is limited. This often forces extra production, wasting more time and resources. Many market standard protocols also fail to preserve native antigen conformation, increasing the risk of antibodies that bind the wrong form and prove ineffective in real assays.

All the Benefits of Immunization, Without the Drawbacks

Save Time
- 50% faster than competitors
- Save 4 weeks of your project’s timeline
Biologically relevant results
- Preserve your antigen native conformation
- Maximize your chances of success
Complex or scarce antigen?
- Use 50% less antigen
- No need to waste precious time and money on antigen production

Ready to develop custom antibodies in record time

RocketAbs is integrated into our antibody discovery workflows to improve success rates on challenging targets. It combines speed and the advantages of an in-vivo response. You receive custom monoclonal antibodies ready for development in record time, whether generated via Single B Cell screening or Hybridoma.